Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Michalski

Showing results (241-250 of 259) with videos related to

Pageof 26
Sort By:
Plos One|June 16, 2023
Supporting SURgery with GEriatric Co-Management and AI (SURGE-Ahead): A study protocol for the development of a digital geriatricianChristoph Leinert, Marina Fotteler, Thomas Derya Kocar, et al.
Cell Reports. Medicine|February 6, 2025
Disrupting AGR2/IGF1 paracrine and reciprocal signaling for pancreatic cancer therapyHongzhen Li, Zhiheng Zhang, Zhao Shi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 14, 2019
Long-course preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for clinical T4 and fixed clinical T3 rectal cancer: long-term results of the randomized Polish II studyB Ciseł, L Pietrzak, W Michalski, et al.
Translational Oncology|September 1, 2024
Metavert synergises with standard cytotoxics in human PDAC organoids and is associated with transcriptomic signatures of therapeutic responseJingyu An, Roma Kurilov, Teresa Peccerella, et al.
JAMA Network Open|August 2, 2024
Preoperative Chemoradiotherapy vs Chemotherapy for Adenocarcinoma of the Esophagogastric Junction: A Network Meta-AnalysisUlrich Ronellenfitsch, Juliane Friedrichs, Emilie Barbier, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 23, 2016
Does the addition of oxaliplatin to preoperative chemoradiation benefit cT4 or fixed cT3 rectal cancer treatment? A subgroup analysis from a prospective studyK Wiśniowska, A Nasierowska-Guttmejer, W Polkowski, et al.
Oncogene|August 8, 2025
ALDH1A3 promotes aggressive basal-like pancreatic cancer through an AP-1/RUNX2 enhancer networkXiaoping Zou, Shuang Nie, Jing Cao, et al.
International Journal of Epidemiology|January 13, 2018
Risk of pancreatic cancer associated with family history of cancer and other medical conditions by accounting for smoking among relativesE Molina-Montes, P Gomez-Rubio, M Márquez, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|September 21, 2021
Gallbladder disease and pancreatic cancer risk: a multicentric case-control European studyV Rosato, P Gómez-Rubio, E Molina-Montes, et al.
Nature Communications|February 2, 2026
Publisher Correction: Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosisAlberto Langtry, Raul Rabadan, Lola Alonso, et al.
Pageof 26

Showing results (241-250 of 259) with videos related to

Sort By:
Pageof 26
Plos One|June 16, 2023
Supporting SURgery with GEriatric Co-Management and AI (SURGE-Ahead): A study protocol for the development of a digital geriatricianChristoph Leinert, Marina Fotteler, Thomas Derya Kocar, et al.
Cell Reports. Medicine|February 6, 2025
Disrupting AGR2/IGF1 paracrine and reciprocal signaling for pancreatic cancer therapyHongzhen Li, Zhiheng Zhang, Zhao Shi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 14, 2019
Long-course preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for clinical T4 and fixed clinical T3 rectal cancer: long-term results of the randomized Polish II studyB Ciseł, L Pietrzak, W Michalski, et al.
Translational Oncology|September 1, 2024
Metavert synergises with standard cytotoxics in human PDAC organoids and is associated with transcriptomic signatures of therapeutic responseJingyu An, Roma Kurilov, Teresa Peccerella, et al.
JAMA Network Open|August 2, 2024
Preoperative Chemoradiotherapy vs Chemotherapy for Adenocarcinoma of the Esophagogastric Junction: A Network Meta-AnalysisUlrich Ronellenfitsch, Juliane Friedrichs, Emilie Barbier, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 23, 2016
Does the addition of oxaliplatin to preoperative chemoradiation benefit cT4 or fixed cT3 rectal cancer treatment? A subgroup analysis from a prospective studyK Wiśniowska, A Nasierowska-Guttmejer, W Polkowski, et al.
Oncogene|August 8, 2025
ALDH1A3 promotes aggressive basal-like pancreatic cancer through an AP-1/RUNX2 enhancer networkXiaoping Zou, Shuang Nie, Jing Cao, et al.
International Journal of Epidemiology|January 13, 2018
Risk of pancreatic cancer associated with family history of cancer and other medical conditions by accounting for smoking among relativesE Molina-Montes, P Gomez-Rubio, M Márquez, et al.
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|September 21, 2021
Gallbladder disease and pancreatic cancer risk: a multicentric case-control European studyV Rosato, P Gómez-Rubio, E Molina-Montes, et al.
Nature Communications|February 2, 2026
Publisher Correction: Deciphering the role of complement system genes in pancreatic cancer susceptibility and prognosisAlberto Langtry, Raul Rabadan, Lola Alonso, et al.
Pageof 26